The clinical importance of interstitial lung abnormality (ILA) is increasingly recognized. In
July 2020, the Fleischner Society published a position paper about ILA. The purposes of this …

Many patients with interstitial lung disease (ILD) develop pulmonary fibrosis, which can lead
to reduced quality of life and early mortality. Patients with fibrotic ILD often have …

The term interstitial lung abnormalities refers to specific CT findings that are potentially
compatible with interstitial lung disease in patients without clinical suspicion of the disease …

Background Screening for lung cancer with low radiation dose computed tomography has a
strong evidence base, is being introduced in several European countries and is …

Background Surveys and retrospective studies of patients with idiopathic pulmonary fibrosis
(IPF) have shown a significant diagnostic delay. However, the causes and risk factors for this …

The incidental discovery of pre-clinical interstitial lung disease (ILD) has led to the
designation of interstitial lung abnormalities (ILA), a radiological entity defined as the …

Background The association between interstitial lung abnormalities (ILAs) and long-term
outcomes has not been reported in Asian health screening populations. Purpose To …

Rationale: Incidental parenchymal abnormalities detected on chest computed tomography
scans are termed interstitial lung abnormalities (ILAs). ILAs may represent early interstitial …

Background Some interstitial lung diseases are associated with lung cancer. However, it is
unclear whether asymptomatic interstitial lung abnormalities convey an independent risk …

Interstitial lung abnormality (ILA) is defined as an interstitial change detected incidentally on
CT images. It is seen in 4%–9% of smokers and 2%–7% of nonsmokers. ILA has a tendency …